Hepatitis C Information - ARROW THERAPEUTICS SELECTS HEP C CLINICAL CANDIDATE

ARROW THERAPEUTICS SELECTS HEP C CLINICAL CANDIDATE
Asia Pulse via Yahoo! Australia & NZ Finance - Feb 05 11:55 PM
Technology Save to My Web

Hep C Patent Case Settled
Red Herring - Feb 10 9:08 AM
Biopharma firm Innogenetics resolves patent suit with Third Wave Technologies over hepatitis C testing kit.Save to My Web

'Missing patients' in Hep C infection risk
The Scotsman: Scotland News - Jan 31 6:36 PM
NHS patients may be unaware they have contracted hepatitis C through blood transfusions, Scottish health officials admitted yesterday.Save to My Web

Arrow Therapeutics Selects Hep C Clinical Candidate
Asia Pulse via Yahoo! Australia & NZ News - Feb 05 11:55 PM
(Full text of a statement. Contact details follow below.) LONDON, Feb. 6 /PRNewswire-AsiaNet/ -- Arrow Therapeutics, the London based antiviral drug discovery and development company, has announced that its lead Hepatitis C compound has entered full pre-clinical development. Originating from Arrow's focused chemical library and optimized in-house, the compound (A-831) has shown potent activity in Save to My Web